Dyslipidemia in Type 2 Diabetes and the Effects of Thiazolidinediones

This publication has 89 references indexed in Scilit:

• Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
  Diabetes Care, 2002
• Standards of Medical Care for Patients With Diabetes Mellitus
  Diabetes Care, 2002
• Impaired Non-Esterified Fatty Acid Suppression is Associated with Endothelial Dysfunction in Insulin Resistant Subjects
  Hormone and Metabolic Research, 2001
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998
• Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Plasma Oxidizability in Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance, and NIDDM
  Diabetes Care, 1995
• Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987